Latest "National Academy Sciences approves expel harassers" News Stories - Page: 2

Waters Corporation Announces 2025 Sustainability Goals

The company advances its sustainability initiatives by announcing first-ever five-year goals and committing to reporting its progress annually Waters Corporation (NYSE:WAT) today announced its 2025 sustainability goals and simultaneously announced a commitment to report its sustainability progress annually. These goals were developed following a comprehensive materiality assessment and are publi...

---

Aro Biotherapeutics Names Seasoned Biopharma Industry Veteran Scott Greenberg as Vice President, Business Development and Alliance Management

Aro Biotherapeutics Company announces that Scott Greenberg has joined the company as Vice President, Business Development and Alliance Management. He brings to the company a wealth of experience across a number of functional disciplines in both oncology and immunology garnered at Roivant Sciences and Celgene Corporation. “Scott’s diverse experience at both large and small biopharmaceutical ...

EnChroma Launches Scenic Viewers for Color Blindness in Partnership with SeeCoast

– Color Blind Visitors to State Parks and Scenic Spots Can Experience the Colors at Iconic Locations With Special Viewers – EnChroma, Inc. – creators of patented eyewear for color blindness – today announced that its assistive lens technology will be available in scenic viewers manufactured by SeeCoast Manufacturing Company. EnChroma’s lens technology will enable people with red-green ...

---

Columbia Care Strengthens Leadership Team with Appointment of Jesse Channon as Chief Growth Officer

Newly created role will focus on digital capabilities, dispensary growth, corporate branding, launching Columbia National Credit (CNC) among network of partners nationwide and new product commercialization and adoption Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis i...

ZYUS Life Sciences Receives Processing Licence from Health Canada to Produce Medical Cannabis Products

Extraction, formulation and production of medical cannabinoid-based therapeutics expected to begin during first quarter 2020 ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) is pleased to announce that effective December 6, 2019, it received a “3 year” Standard Processing Licence from Health Canada for its Saskatoon-based Phase I processing facility (the “Processing Licence”). T...

 Biotia, Pioneering Pathogen Detection Company, Raises $2.4M Seed Round, Expands Scientific Advisory Board

Biotia, a health tech company leveraging next-generation DNA sequencing (NGS) and artificial intelligence (AI) software for precision infectious disease detection and diagnosis, today announced an oversubscribed $2.4M seed raise and expanded scientific advisory board . Dr. Yiannis Monovoukas, Co-Founder and Managing Partner of Falcon III Ventures, a Boston-based biotech fund who

Crossix Continues to Expand Health Data Network

Reinforces commitment to building the largest privacy-safe connected patient data network for life sciences Crossix announced today it has added several new data partners and sources as the company continues to expand its network of connected health data. Additional Rx and medical claims data will allow an even more complete picture of the patient journey, including for specialty prescription p...

Perceptive Advisors Closes Inaugural $210 Million Perceptive Xontogeny Venture Fund to Support Early-Stage Biotech Startups​

- New fund plans to lead Series A financings in 8 to 10 companies - - Fund will favor companies seeded at the Xontogeny accelerator, which allows operational and development efficiency to entrepreneur-led startups - Perceptive Advisors, an investment management firm focused in life sciences, today announced the closing of its inaugural venture capital fund, the Perceptive Xontogeny Venture Fun...

Quellis Biosciences Inc. Announces $17 Million Series A Financing

- Lead program aims to develop next-generation antibody therapy for a rare and life-threatening disease - - Series A financing led by the Perceptive Xontogeny Venture Fund - Quellis Biosciences Inc., an emerging biopharmaceutical company focused on discovering best-in-class new molecules to treat serious rare diseases, today announced its emergence from stealth operations and that it has close...

ATF Medical Welcomes Karissa Peffer as Senior Coordinator of Adaptive Housing Solutions

Karissa Peffer recently joined ATF Medical as senior coordinator of adaptive housing solutions. ATF Medical provides comprehensive medical equipment and adaptive housing solutions to the workers’ compensation industry. ATF Medical matches a therapist, usually an occupational therapist or assistive technology professional, with a contractor to assess the injured worker’s home from both clini...

INVEST 2020 early bird registration ends today so reserve your spot to see “Reverse pitch” with hospital innovation leaders,

Early bird pricing for MedCity INVEST 2020 ends today so register now for this national investing conference for a chance to see hospital innovation leaders take part in a reverse pitch among other interesting sessions.

Freyr Eyes Strategic Market Growth with New Corporate Appointments

Freyr Solutions, a leading Regulatory solutions and services provider, announces two new corporate appointments to its senior management eyeing a strategic market growth. The new team includes: Robert MacDougall, Vice President, Business Development Claudia Ribaudo Fields, Vice President, Global Sales Rob joined Freyr on Sep 9, 2019, and currently is based at the company’s headquarters,...

Eleven Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation

Specialty pharmacists within the Excelera Network continue to prove strong commitment to their trade. MINNEAPOLIS (PRWEB) December 10, 2019 Excelera®, the company behind the Excelera Network, a nationwide network of leading health systems and academic medical centers with specialty pharmacies, today announced that eleven member pharmacists have earned or recertified the exclusive Certified S...

ISPE Global Forum Explores Innovative “Next Generation” Facilities of the Future

This 2020 ISPE Facilities of the Future Conference will explore the changing landscape of pharmaceutical manufacturing to offer solutions and strategies for facilities to be competitive and cost-effective while ensuring quality medicines. NORTH BETHESDA, Md. (PRWEB) December 10, 2019 The International Society for Pharmaceutical Engineering (ISPE) announced its 2020 ISPE Facilities of the Future C...

Cassava Sciences: Shortseller Squarepoint Ops zieht sich spürbar zurück

Austin (www.aktiencheck.de) - Leerverkäufer Squarepoint Ops LLC fährt Netto-Leerverkaufsposition in Aktien von Cassava Sciences deutlich zurück: Die Shortseller von Squarepoint Ops LLC ziehen sich ...

Healthcare trends 2020 – the biggest shifts changing lives and life sciences

By Julie Adrian

FDA approves Aptar’s Unidose device to treat acute repetitive seizures

AptarGroup has secured approval from the US Food and Drug Administration (FDA) for its Unidose Liquid System as a nasal rescue treatment for frequent seizure activity. The Unidose The post FDA approves Aptar’s Unidose device to treat acute repetitive seizures appeared first on NS Medical Devices.

Candela Corp Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110

Candela Corp Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by ena...

Jaguar Health Subsidiary Napo Pharmaceuticals to Host HIV Activism Digital Summit December 13, 2019 at 3 p.m. Eastern

SAN FRANCISCO, CA / ACCESSWIRE / December 10, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), today announced that the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc. ("Napo"), is hosting an HIV Activism Digital Summit on Friday, December 13, 2019 from 3 p.m. to 5 p.m. Eastern. The summit will feature commentary by prominent HI...

Farrer Park Hospital Implements Non-Invasive Treatment for Prostate Cancer Patients in Singapore

SINGAPORE, Dec. 10, 2019 /PRNewswire/ -- Farrer Park Hospital is pleased to announce that it is the first in South East Asia to have implemented the Focal One® High-Intensity Frequency Ultrasound (HIFU) Robotic Technology, a non-invasive prostate cancer treatment, for patients with early-stage prostate cancer. Prostate cancer ...

ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials

ImmunOs Therapeutics AG, a Swiss bio-technology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced today the closing of a Series A financing of CHF 15 million. The round was co-led by the Basel life sciences venture capital firm BioMedPartners and Pfizer Ventures, the venture capital arm of Pfizer Inc. (NYSE: PFE), with the part...

Health Tip: Choosing a Pediatrician

-- Pediatricians are specially trained to treat children from birth through adolescence and into the patient's young adult years, says the American Academy of Family Physicians. To find a qualified pediatrician for your child, the American Academy...

Kristian Jürgensen promoted to Chief Commercial Officer as The RSA Group expands

London, UK, 10th December 2019 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced today that Kristian Jürgensen has been promoted to Chief Commercial Officer effective as of December 2019. Kristian joined the company as Managing Partner for Germany and Switzerland in May 2019 and has proved himself to be a phenomenal driver of growth and focus at the Co...

Study: Claim lines for Lyme disease have increased 117% from 2007 to 2018

From 2007 to 2018, claim lines with diagnoses of Lyme disease increased nationally 117 percent, according to a new white paper from FAIR Health, a national, independent nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information.

University of Nottingham Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $220

SummaryUniversity of Nottingham UON is a research university which offers undergraduate, postgraduate and professional development programs. The university provides educational and research programs in the areas of arts, science, engineering, social sciences as well as medicine and health sciences. It also provides academic courses which include American and Canadian studies, archaeology, English...